Vanlent Anne

Vanlent Anne is listed in filings as Director at Trevi Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including 3 public disclosures. Recent filings connect the profile to Trevi Therapeutics, Inc. (TRVI). The current snapshot covers public activity from Jun 14, 2024 to Jun 4, 2026. Reported amounts are shown as $470.8K to $83.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.